Annual EBITDA
-$141.12 M
-$52.05 M-58.43%
December 31, 2022
Summary
- As of February 10, 2025, RXDX annual EBITDA is -$141.12 million, with the most recent change of -$52.05 million (-58.43%) on December 31, 2022.
- During the last 3 years, RXDX annual EBITDA has fallen by -$125.20 million (-786.23%).
Performance
RXDX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$48.47 M
-$9.92 M-25.73%
March 31, 2023
Summary
- As of February 10, 2025, RXDX quarterly EBITDA is -$48.47 million, with the most recent change of -$9.92 million (-25.73%) on March 31, 2023.
- Over the past year, RXDX quarterly EBITDA has dropped by -$16.46 million (-51.43%).
Performance
RXDX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$157.62 M
-$16.46 M-11.66%
March 31, 2023
Summary
- As of February 10, 2025, RXDX TTM EBITDA is -$157.62 million, with the most recent change of -$16.46 million (-11.66%) on March 31, 2023.
- Over the past year, RXDX TTM EBITDA has dropped by -$49.78 million (-46.16%).
Performance
RXDX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RXDX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.4% | -51.4% | -46.2% |
| 3 y3 years | -786.2% | -657.6% | -2363.5% |
| 5 y5 years | -786.2% | -657.6% | -2363.5% |
RXDX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +58.4% | at low | +62.5% | at low | +76.9% | at low |
| 5 y | 5-year | +786.2% | at low | +657.6% | at low | +2363.5% | at low |
| alltime | all time | +786.2% | at low | +657.6% | at low | +2363.5% | at low |
Prometheus Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$48.47 M(+25.7%) | -$157.62 M(+11.7%) |
| Dec 2022 | -$141.12 M(+58.4%) | -$38.55 M(+3.9%) | -$141.15 M(+6.6%) |
| Sep 2022 | - | -$37.11 M(+10.8%) | -$132.43 M(+8.0%) |
| Jun 2022 | - | -$33.49 M(+4.6%) | -$122.57 M(+13.7%) |
| Mar 2022 | - | -$32.01 M(+7.3%) | -$107.84 M(+21.1%) |
| Dec 2021 | -$89.08 M | -$29.83 M(+9.5%) | -$89.08 M(+31.4%) |
| Sep 2021 | - | -$27.24 M(+45.3%) | -$67.78 M(+41.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$18.75 M(+41.6%) | -$47.97 M(+34.2%) |
| Mar 2021 | - | -$13.25 M(+55.1%) | -$35.75 M(+23.7%) |
| Dec 2020 | -$28.90 M(+81.5%) | -$8.54 M(+14.9%) | -$28.90 M(+42.0%) |
| Sep 2020 | - | -$7.43 M(+13.8%) | -$20.36 M(+57.5%) |
| Jun 2020 | - | -$6.53 M(+2.0%) | -$12.93 M(+102.0%) |
| Mar 2020 | - | -$6.40 M | -$6.40 M |
| Dec 2019 | -$15.92 M | - | - |
FAQ
- What is Prometheus Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Prometheus Biosciences?
- What is Prometheus Biosciences annual EBITDA year-on-year change?
- What is Prometheus Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly EBITDA year-on-year change?
- What is Prometheus Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Prometheus Biosciences?
- What is Prometheus Biosciences TTM EBITDA year-on-year change?
What is Prometheus Biosciences annual EBITDA?
The current annual EBITDA of RXDX is -$141.12 M
What is the all time high annual EBITDA for Prometheus Biosciences?
Prometheus Biosciences all-time high annual EBITDA is -$15.92 M
What is Prometheus Biosciences annual EBITDA year-on-year change?
Over the past year, RXDX annual EBITDA has changed by -$52.05 M (-58.43%)
What is Prometheus Biosciences quarterly EBITDA?
The current quarterly EBITDA of RXDX is -$48.47 M
What is the all time high quarterly EBITDA for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly EBITDA is -$6.40 M
What is Prometheus Biosciences quarterly EBITDA year-on-year change?
Over the past year, RXDX quarterly EBITDA has changed by -$16.46 M (-51.43%)
What is Prometheus Biosciences TTM EBITDA?
The current TTM EBITDA of RXDX is -$157.62 M
What is the all time high TTM EBITDA for Prometheus Biosciences?
Prometheus Biosciences all-time high TTM EBITDA is -$6.40 M
What is Prometheus Biosciences TTM EBITDA year-on-year change?
Over the past year, RXDX TTM EBITDA has changed by -$49.78 M (-46.16%)